Skip to Content

Janumet XR

In the US, Janumet XR (metformin/sitagliptin systemic) is a member of the drug class antidiabetic combinations and is used to treat Diabetes, Type 2.

US matches:

Ingredient matches for Janumet XR

Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Janumet XR in the following countries:

  • Canada
  • Chile
  • Hong Kong
  • Malaysia
  • Singapore
  • Switzerland
  • United States

Sitagliptin

Sitagliptin is reported as an ingredient of Janumet XR in the following countries:

  • Hong Kong
  • Malaysia
  • Singapore
  • United States

Sitagliptin phosphate (a derivative of Sitagliptin) is reported as an ingredient of Janumet XR in the following countries:

  • Canada

Sitagliptin phosphate hydrate (a derivative of Sitagliptin) is reported as an ingredient of Janumet XR in the following countries:

  • Chile
  • Switzerland

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide